⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adnexal carcinoma

Every month we try and update this database with for adnexal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Improved Diagnosis of Ovarian CancerNCT05842629
Ovarian Neoplas...
Ovarian Cancer
Ovarian Cysts
Adnexal Mass
Adnexal Lesion
Adnexal Carcino...
Adnexal Neoplas...
- University of Aarhus
Improved Diagnosis of Ovarian CancerNCT05842629
Ovarian Neoplas...
Ovarian Cancer
Ovarian Cysts
Adnexal Mass
Adnexal Lesion
Adnexal Carcino...
Adnexal Neoplas...
- University of Aarhus
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersNCT02978625
Adenoid Cystic ...
Adnexal Carcino...
Anaplastic Larg...
Anaplastic Larg...
Apocrine Carcin...
Cylindrocarcino...
Digital Papilla...
Endocrine Mucin...
Extramammary Pa...
Extraocular Cut...
Hidradenocarcin...
Keratoacanthoma
Malignant Sweat...
Merkel Cell Car...
Microcystic Adn...
NK-Cell Lymphom...
Papillary Adeno...
Porocarcinoma
Primary Cutaneo...
Recurrent Matur...
Recurrent T-Cel...
Refractory Anap...
Refractory Matu...
Refractory Merk...
Refractory Myco...
Refractory Prim...
Refractory Skin...
Refractory T-Ce...
Sezary Syndrome
Signet Ring Cel...
Skin Basal Cell...
Skin Basosquamo...
Skin Squamous C...
Spiradenocarcin...
Squamoid Eccrin...
Squamous Cell C...
Sweat Gland Car...
Trichilemmal Ca...
Vulvar Squamous...
Biopsy
Biospecimen Col...
Computed Tomogr...
Laboratory Biom...
Nivolumab
Positron Emissi...
Talimogene Lahe...
18 Years - National Cancer Institute (NCI)
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin CancersNCT02978625
Adenoid Cystic ...
Adnexal Carcino...
Anaplastic Larg...
Anaplastic Larg...
Apocrine Carcin...
Cylindrocarcino...
Digital Papilla...
Endocrine Mucin...
Extramammary Pa...
Extraocular Cut...
Hidradenocarcin...
Keratoacanthoma
Malignant Sweat...
Merkel Cell Car...
Microcystic Adn...
NK-Cell Lymphom...
Papillary Adeno...
Porocarcinoma
Primary Cutaneo...
Recurrent Matur...
Recurrent T-Cel...
Refractory Anap...
Refractory Matu...
Refractory Merk...
Refractory Myco...
Refractory Prim...
Refractory Skin...
Refractory T-Ce...
Sezary Syndrome
Signet Ring Cel...
Skin Basal Cell...
Skin Basosquamo...
Skin Squamous C...
Spiradenocarcin...
Squamoid Eccrin...
Squamous Cell C...
Sweat Gland Car...
Trichilemmal Ca...
Vulvar Squamous...
Biopsy
Biospecimen Col...
Computed Tomogr...
Laboratory Biom...
Nivolumab
Positron Emissi...
Talimogene Lahe...
18 Years - National Cancer Institute (NCI)
Improved Diagnosis of Ovarian CancerNCT05842629
Ovarian Neoplas...
Ovarian Cancer
Ovarian Cysts
Adnexal Mass
Adnexal Lesion
Adnexal Carcino...
Adnexal Neoplas...
- University of Aarhus
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: